Responses
Consensus statement
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016Hepatitis B Virus and tumour necrosis factor alpha blocking agentsShow More
Dear Editor,
With the increasing number of patients now being treated with tumour necrosis factor alpha (TNF-alpha) blocking agents, the publication of an updated consensus statement in the Advances in Targeted Therapies VI supplement of Annals of the Rheumatic Diseases was both timely and relevant. However we notice that conflicting advice on the management of patients with Hepatitis B Virus (HBV) infection is...
Conflict of Interest:
None declared.